Literature DB >> 19745755

Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment.

Judith M Haissman1, Lasse S Vestergaard, Samuel Sembuche, Christian Erikstrup, Bruno Mmbando, Samuel Mtullu, Martha M Lemnge, Jan Gerstoft, Henrik Ullum.   

Abstract

OBJECTIVE: To evaluate the role immune activation leading to the production and circulation of cytokines has in the pathogenesis of HIV infection in sub-Saharan Africa and the effect of antiretroviral treatment (ART) on these parameters.
METHODS: Plasma concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, IL-10, and IL-1 receptor antagonist; plasma HIV RNA; hemoglobin concentration; and white blood cells were measured in 229 HIV-infected, 54 HIV-uninfected, and after 2 and 4 months, respectively, of ART in 35 eligible individuals in northeastern Tanzania.
RESULTS: Plasma levels of tumor necrosis factor-alpha, IL-6, IL-8, monocyte chemotactic protein-1, and IL-1 receptor antagonist were significantly higher in HIV-infected individuals compared with HIV-uninfected individuals and also significantly higher in HIV-infected individuals with CD4 cell counts below 200 cells per microliter than individuals with CD4 cell counts above 200 cells per microliter. HIV RNA was the strongest predictor of all cytokine expression in multivariate analysis. ART leads to a decrease in all cytokines to levels close to those of HIV-uninfected individuals.
CONCLUSIONS: Our findings support the role of HIV viral replication as the most important promoter of immune activation and prove the importance of ART in reducing immune activation and viral replication even in sub-Saharan Africa where patients are exposed to an abundance of other infectious agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745755     DOI: 10.1097/QAI.0b013e3181b627dc

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  17 in total

1.  The erythrocyte sedimentation rate in HIV: a neglected parameter?

Authors:  David M Lowe
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

2.  HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?

Authors:  Juan C Hernandez; Georges St Laurent; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

3.  Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers.

Authors:  Gregory H Taylor; Adrienne A Williams; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

4.  Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.

Authors:  Marla J Keller; Aileen P McGinn; Yungtai Lo; Ashley Huber; Lilia Espinoza; Howard Minkoff; Christine Colie; Marek J Nowicki; Gypsyamber D'Souza; Kathryn Anastos
Journal:  Am J Reprod Immunol       Date:  2016-05-05       Impact factor: 3.886

5.  Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.

Authors:  Christophe Vanpouille; Andrea Introini; Sheldon R Morris; Leonid Margolis; Eric S Daar; Michael P Dube; Susan J Little; David M Smith; Andrea Lisco; Sara Gianella
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

6.  Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.

Authors:  Cynthia Gay; Oliver Dibben; Jeffrey A Anderson; Andrea Stacey; Ashley J Mayo; Philip J Norris; JoAnn D Kuruc; Jesus F Salazar-Gonzalez; Hui Li; Brandon F Keele; Charles Hicks; David Margolis; Guido Ferrari; Barton Haynes; Ronald Swanstrom; George M Shaw; Beatrice H Hahn; Joseph J Eron; Persephone Borrow; Myron S Cohen
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

7.  Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.

Authors:  Otto O Yang; Theodoros Kelesidis; Robert Cordova; Homayoon Khanlou
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-11       Impact factor: 1.723

8.  Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.

Authors:  Jessica Nyström; Jenny Stenkvist; Amanda Häggblom; Ola Weiland; Piotr Nowak
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

9.  Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy.

Authors:  Frederikke F Rönsholt; Henrik Ullum; Terese L Katzenstein; Jan Gerstoft; Sisse R Ostrowski
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

Review 10.  Systematic review of antiretroviral-associated lipodystrophy: lipoatrophy, but not central fat gain, is an antiretroviral adverse drug reaction.

Authors:  Reneé de Waal; Karen Cohen; Gary Maartens
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.